Don’t Buy Someone Else’s IP Problem
A column authored by Jason Balich titled “Don’t Buy Someone Else’s IP Problem” was published in the American Institute of Chemical Engineers’ Chemical Engineering Progress (CEP) Magazine. In this arti...
Articles
One Rung Up the Ladder: How Products That Practice Prior Art Can Inform Lost Profits Calculations
An article co-authored by Karen Gover (Wolf Greenfield), Marie McKiernan (Wolf Greenfield), Animesh Giri (The Brattle Group), Jonathan Lee (The Brattle Group) titled “One Rung Up the Ladder: How Produ...
IP Diligence in the Age of AI: Why Standard Review Is No Longer Enough
IP diligence comes in many forms—and in today’s environment, it demands more than ever before. Whether the context is a financing round, a strategic partnership, or a full acquisition, the intellectua...
Top Seven Things to Consider When Protecting and Patenting Medical Technology
Co-authored by: Matt Grady, Shareholder, Wolf Greenfield l John Harmon, Shareholder, Wolf Greenfield l Carol Burnton, Principal, FPA Patent Attorneys l Stuart Irvine, Principal, FPA Patent Attorneys
Building Lasting IP Protection
A column authored by Jason Balich titled “Building Lasting IP Protection” was published in the American Institute of Chemical Engineers’ Chemical Engineering Progress (CEP) Magazine. In this article, ...
A Comparative Overview of Patenting AI Inventions
Co-authored by: Lin Li (Wolf Greenfield), Ed Walsh (Wolf Greenfield), Nancy Song (Linda Liu & Partners), and Holger Veenhuis (Eisenführ Speiser) AI flies above the geographical frontiers that ofte...
Patent Term Extension: Challenges with Defining and Claiming Approved Biologics
An article by Jessica von Reyn “Patent Term Extension: Challenges with Defining and Claiming Approved Biologics” was published in Pharmaceutical Executive®. As biologics continue to transform modern t...
United States Annual Review: The Seventy-Eighth Year of Administration of the Lanham Act of 1946
John Welch co-authored the January-February 2026 edition of The Trademark Reporter, The Law Journal of The International Trademark Association (INTA). Titled “United States Annual Review: The Seventy-...
Staying IP Due Diligence Ready: A Practical Guide for In-House Counsel
Introduction For in-house counsel, IP due diligence is not simply a checklist exercise—it is a real-time test of the company’s long-term intellectual property strategy. With transaction timelines ofte...
AI as a Bridge Between In-House and Outside Counsel
An article by Matt Grady titled “AI as a Bridge Between In-House and Outside Counsel” was published in Managing IP. As AI adoption accelerates across legal departments, it offers meaningful efficienci...
Limits on Patent Licensing: Post-Expiration Royalties, Reach-Through Royalties, and Misuse Risks
Patent owners have significant leverage at the negotiating table, but that leverage has limits. In various circumstances, the Supreme Court has held that while a patentee may refuse to license its inv...
A Look Ahead: Key Intellectual Property Legal Developments in 2025—and What to Expect in 2026
This past year saw major shifts affecting patent adjudication, prosecution strategy, biotechnology claiming, artificial intelligence, standard-essential patents, and litigation trends. Moving into 202...